Q32 Bio Inc. (QTTB) Operating Leases (2020 - 2026)

Q32 Bio has reported Operating Leases for 7 years, with the latest figure at $4.6 million in Q2 2026.

• On a quarterly basis, Operating Leases fell 13.88% year-over-year to $4.6 million in Q2 2026; TTM through Jun 2026 was $4.6 million, a 13.88% decrease from a year earlier, with the FY2025 full-year figure at $4.9 million, down 12.3% from the prior year.
• Operating Leases was $4.6 million for Q2 2026 at Q32 Bio, down from $4.8 million in the prior quarter.
• The five-year high for Operating Leases was $28.3 million in Q3 2022, with the low at $4.6 million in Q2 2026.
• Average Operating Leases over 5 years is $13.6 million, with a median of $6.0 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Operating Leases soared 144.67% in 2022, then tumbled 78.19% in 2024.
• Over 5 years, Operating Leases stood at $27.9 million in 2022, then plunged by 77.62% to $6.2 million in 2023, then retreated by 9.8% to $5.6 million in 2024, then decreased by 12.3% to $4.9 million in 2025, then slipped by 7.73% to $4.6 million in 2026.
• The last three Operating Leases figures came in at $4.6 million (Q2 2026), $4.8 million (Q1 2026), and $4.9 million (Q4 2025), per Business Quant data.